Literature DB >> 26162360

Risk of incident active tuberculosis and use of corticosteroids.

C-C Lai1, M-T G Lee2, S-H Lee3, S-H Lee3, S-S Chang4, C-C Lee5.   

Abstract

OBJECTIVE: To examine the association between corticosteroid use and risk of active tuberculosis (TB) disease.
METHODS: We conducted a population-based nested case-control study based on Taiwan's National Health Insurance Research Database between January 1999 and December 2011. Each case of incident active TB was matched to 100 controls using a risk-set sampling scheme.
RESULTS: From a participant cohort of 1 million, 6229 cases of new active TB and 622,900 controls were identified. Current, recent, past, ever and chronic use of corticosteroids were associated with an increased risk of developing incident active TB, with adjusted rate ratios of respectively 2.76 (95%CI 2.44-3.11), 1.99 (95%CI 1.73-2.31), 1.17 (95%CI 1.06-1.29), 1.60 (95%CI 1.49-1.72), and 1.58 (95%CI 1.43-1.75). For subgroup analysis, the increased risk of TB in chronic corticosteroids users was substantially higher in subjects aged ≤70 years and female subjects.
CONCLUSION: In this relatively high TB prevalence setting, we found that use of corticosteroids was associated with an increased risk of TB. Current use of corticosteroids was associated with the highest risk of TB.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26162360     DOI: 10.5588/ijtld.15.0031

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

Review 1.  Hepatic and Intra-abdominal Tuberculosis: 2016 Update.

Authors:  Richard P T Evans; Moustafa Mabrouk Mourad; Lee Dvorkin; Simon R Bramhall
Journal:  Curr Infect Dis Rep       Date:  2016-12       Impact factor: 3.725

Review 2.  Does tuberculosis threaten our ageing populations?

Authors:  Rachel Byng-Maddick; Mahdad Noursadeghi
Journal:  BMC Infect Dis       Date:  2016-03-11       Impact factor: 3.090

3.  Glucocorticoids Suppress Antimicrobial Autophagy and Nitric Oxide Production and Facilitate Mycobacterial Survival in Macrophages.

Authors:  Jinli Wang; Ruining Wang; Hui Wang; Xiaofan Yang; Jiahui Yang; Wenjing Xiong; Qian Wen; Li Ma
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

4.  Activated pulmonary tuberculosis in a patient with melanoma during PD-1 inhibition: a case report.

Authors:  Wan He; Xiangmei Zhang; Wenwen Li; Cheng Kong; Yuanyang Wang; Lianyu Zhu; Ruilian Xu; Guofang Deng; Peize Zhang
Journal:  Onco Targets Ther       Date:  2018-10-24       Impact factor: 4.147

5.  Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids.

Authors:  Jun Won Park; Jeffrey R Curtis; Hajeong Lee; Jung-Kyu Lee; Yeong Wook Song; Eun Bong Lee
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

6.  Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in China.

Authors:  Xiaoqing Liu; Lifan Zhang; Fengchun Zhang; Xiaofeng Zeng; Yan Zhao; Qian Wang; Shengyun Liu; Xiaoxia Zuo; Zhiyi Zhang; Huaxiang Wu; Sheng Chen; Hongbin Li; Ping Zhu; Lijun Wu; Wencheng Qi; Yi Liu; Miaojia Zhang; Huaxiang Liu; Dong Xu; Wenjie Zheng; Yueqiu Zhang; Xiaochun Shi; Lishuai Han; Yaou Zhou; Yanping Zhao; Wenwen Wang; Ting Li; Ning Tie; Kui Zhang; Cainan Luo; Baoqi Gong; Yi Zhao; Chengyin Lv; Lijun Song; Qingjun Wu; Yunyun Fei; Lei Zhang; Hui Luo; Jiaying Sun; Jing Xue; Liyang Gu; Jing Wang; Qing Han; Kuerbanjiang Yimaity; Jiaxin Zhou; Lidan Zhao; Sainan Bian; Wufang Qi; Yanhong Li; Yujing Zhu; Huijun Han; Susu Liao; Gaifen Liu
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

7.  Tuberculosis Reactivation After Severe SARS-COV-2 Pneumonia.

Authors:  Jose Cardoso-Landivar; Maria-Angeles Jiménez-Fuentes; Maria-Luiza De Souza-Galvão
Journal:  Arch Bronconeumol       Date:  2022-04-27       Impact factor: 6.333

Review 8.  Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication).

Authors: 
Journal:  Intest Res       Date:  2018-04-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.